Zoetis reported $53M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
Bristol Myers Squibb BMY:US $ 313M 13M
Charles River Laboratories CRL:US $ 3.7M 5.73M
Eli Lilly And LLY:US $ 81.2M 3.7M
Henry Schein HSIC:US $ 9M 2M
Idexx Laboratories IDXX:US $ 8.32M 1.32M
Illumina ILMN:US $ 6M 0M
IQVIA Holdings Inc IQV:US $ 94M 8M
Laboratory Of America LH:US $ 42.5M 0.3M
Lannett LCI:US $ 14.81M 0.29M
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Patterson Companies PDCO:US $ 5.56M 0.87M
Pfizer PFE:US $ 293M 29M
Teva Pharmaceutical Industries TEVA:US $ 225M 13M
Zoetis ZTS:US $ 53M 0M